Latest News

  • 05/19/2014
    XTL Biopharmaceuticals Further Strengthens Team for Phase II Lupus Trial with Two Additional Experts
    READ MORE >>
  • 04/02/2014
    XTL Biopharmaceuticals Reports Financial and Operational Results for the Full Year 2013
    READ MORE >>
  • 03/30/2014
    Jerusalem Post: "Weizmann professor is not afraid of the big bad wolf"
    READ MORE >>
  • 03/25/2014
    XTL Biopharmaceuticals Retains Expert Consultants in Rheumatology for Phase II Lupus Trial
    READ MORE >>
  • 03/09/2014
    XTL Biopharmaceuticals files to raise $40M on Nasdaq
    READ MORE >>
  • 02/26/2014
    BioPharm Insight - Multiple Myeloma
    READ MORE >>
  • 02/26/2014
    Biopharm Insight - Lupus
    READ MORE >>
  • 01/07/2014
    XTL In-licenses hCDR1, a Phase 2 Clinical Stage Asset for the Treatment of Lupus
    READ MORE >>
  • 07/15/2014
    XTL Biopharmaceuticals' ADRs Commence Trading on NASDAQ Stock Market
    READ MORE >>
  • 07/10/2014
    Approval of Application for Listing the Company's Shares on the NASDAQ
    READ MORE >>
  • 06/12/2013
    XTL BIOPHARMACEUTICALS LTD. PRESENTS ITS INTERIM FINANCIAL STATEMENTS AS OF MARCH 31, 2013
    READ MORE >>
  • 05/30/2013
    XTL BIOPHARMACEUTICALS LTD. PRESENTS ITS INTERIM FINANCIAL STATEMENTS AS OF MARCH 31, 2013
    READ MORE >>
  • 05/08/2013
    XTL BIOPHARMACEUTICALS CONVENES AN ANNUAL GENERAL MEETING
    READ MORE >>
  • 03/24/2013
    XTL BIOPHARMACEUTICALS PRESENTS ITS FINANCIAL STATEMENTS FOR THE YEAR ENDED ON DECEMBER 31, 2012
    READ MORE >>
  • 03/12/2013
    XTL BIOPHARMACEUTICALS ANNOUNCES THE APPROVAL OF THE SETTLEMENT AND THE EXTENSION OF THE WARRANTS (SERIES 2) TO DECEMBER 31, 2013 THE DISTRICT COURT OF TEL AVIV-JAFFA
    READ MORE >>
  • 03/06/2013
    XTL BIOPHARMACEUTICALS AND KITOV MUTUALLY AGRRED TO CEASE NEGOTIATIONS
    READ MORE >>
  • 02/21/2013
    XTL BIOPHARMACEUTICALS FILES A REQUEST WITH THE DISTRICT COURT OF TEL AVIV-JAFFA FOR APPROVAL OF THE SETTLEMENT AND THE EXTENSION OF THE WARRANTS (SERIES 2) TO DECEMBER 31, 2013
    READ MORE >>
  • 02/21/2013
    XTL BIOPHARMACEUTICALS ANNOUNCES RESULTS OF ITS EXTRAORDINARY GENERAL MEETING OF WARRANT (SERIES 2) HOLDERS
    READ MORE >>
  • 02/21/2013
    XTL BIOPHARMACEUTICALS ANNOUNCES RESULTS OF ITS EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS
    READ MORE >>
  • 02/06/2013
    XTL BIOPHARMACEUTICALS ANNOUNCES THE APPROVAL OF THE TEMPORARY ORDER BY THE DISTRICT COURT OF TEL AVIV-JAFFA TO EXTEND THE EXERCISE PERIOD OF WARRANTS (SERIES 2) TO APRIL 30, 2013
    READ MORE >>
  • 02/03/2013
    XTL BIOPHARMACEUTICALS CONVENES GENERAL MEETING OF SHAREHOLDERS AND WARRANT (SERIES 2) HOLDERS
    READ MORE >>
  • 01/30/2013
    XTL BIOPHARMACEUTICALS FILES AN URGENT REQUEST WITH THE DISTRICT COURT OF TEL AVIV-JAFFA FOR A TEMPORARY ORDER TO EXTEND THE EXERCISE PERIOD OF WARRANTS (SERIES 2) TO APRIL 30, 2013 IN ORDER TO PROVIDE SUFFICIENT TIME TO COMPLETE THE NECESSARY PROCEDURES
    READ MORE >>
  • 01/30/2013
    THE DISTRICT COURT OF TEL AVIV-JAFFA APPROVED THE CONVENING AN EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS AND WARRANT HOLDERS
    READ MORE >>
  • 01/29/2013
    XTL BIOPHARMACEUTICALS FILES AN URGENT REQUEST WITH THE DISTRICT COURT OF TEL AVIV-JAFFA FOR SETTLEMENT IN ORDER TO EXTEND THE EXERCISE PERIOD OF WARRANTS (SERIES 2) TO DECEMBER 31, 2013
    READ MORE >>
  • 01/29/2013
    XTL BIOPHARMACEUTICALS FILES AN URGENT REQUEST WITH THE DISTRICT COURT OF TEL AVIV-JAFFA FOR SETTLEMENT IN ORDER TO EXTEND THE EXERCISE PERIOD OF WARRANTS (SERIES 2) TO DECEMBER 31, 2013
    READ MORE >>
  • 01/02/2013
    XTL BIOPHARMACEUTICALS ANNOUNCES THE EXTENSION OF LOCK-UP AGREEMENT WITH FORMER XTEPO SHAREHOLDERS
    READ MORE >>
  • 12/13/2012
    XTL BIOPHARMACEUTICALS ANNOUNCES CHANGES IN NEGOTIATIONS WITH KITOV. EXTRAORDINARY GENERAL MEETING ADJOURNED WITHOUT VOTING
    READ MORE >>
  • 11/28/2012
    XTL BIOPHARMACEUTICALS PROVIDES UPDATED EXTRAORDINARY GENERAL SHAREHOLDER MEETING CONVENING LETTER
    READ MORE >>
  • 11/27/2012
    XTL BIOPHARMACEUTICALS POSTPONES EGM TO DECEMBER 6, 2012
    READ MORE >>
  • 11/25/2012
    XTL BIOPHARMACEUTICALS LTD. PRESENTS ITS INTERIM FINANCIAL STATEMENTS AS OF SEPTEMBER 30, 2012
    READ MORE >>
  • 11/21/2012
    #1 - XTL BIOPHARMACEUTICALS ACQUIRES STAKE IN PROTEOLOGICS LTD.
    READ MORE >>
  • 09/24/2012
    XTL BIOPHARMACEUTICALS – INTERCURE SIGNS A STRATEGIC SERVICE AGREEMENT
    READ MORE >>
  • 09/24/2012
    XTL BIOPHARMACEUTICALS PROVIDES FAVORABLE UPDATE ON NASDAQ LISTING PROCESS
    READ MORE >>
  • 09/10/2012
    XTL BIOPHARMACEUTICALS LTD. ANNOUNCES PROGRESS IN THE ACQUISITION OF KITOV PHARMACEUTICALS LTD
    READ MORE >>
  • 08/30/2012
    XTL BIOPHARMACEUTICALS LTD. PRESENTS ITS INTERIM FINANCIAL STATEMENTS AS OF JUNE 30, 2012
    READ MORE >>
  • 08/23/2012
    XTL BIOPHARMACEUTICALS LTD. ANNOUNCES TERMINATION OF THE AGREEMENT WITH PRESIDIO PHARMACEUTICALS INC.
    READ MORE >>
  • 07/09/2012
    XTL BIOPHARMACEUTICALS LTD. ALLOCATES 7,165,662 SHARES TO INTERCURE LTD.
    READ MORE >>
  • 06/19/2012
    XTL BIOPHARMACEUTICALS LTD. ANNOUNCES ACQUISITION OF KITOV PHARMACEUTICALS LTD.
    READ MORE >>
  • 06/14/2012
    XTL BIOPHARMACEUTICALS LTD. ANNOUNCES AGREEMENT FOR THE ACQUISITION OF CONTROL OVER INTERCURE
    READ MORE >>
  • 06/10/2012
    XTL BIOPHARMACEUTICALS LTD. JOINS "TA BLUETECH-50" INDEX
    READ MORE >>
  • 06/10/2012
    XTL BIOPHARMACEUTICALS LTD. JOINS "TA MIDCAP-50" INDEX
    READ MORE >>
  • 05/29/2012
    XTL BIOPHARMACEUTICALS ANNOUNCES RESULTS OF ITS EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS
    READ MORE >>
  • 05/09/2012
    XTL BIOPHARMACEUTICALS PRESENTS ITS INTERIM FINANCIAL STATEMENTS AS OF MARCH 31, 2012
    READ MORE >>
  • 04/15/2012
    XTL BIOPHARMACEUTICALS LTD. SIGNS LETTER OF INTENT TO ACQUIRE A COMPANY
    READ MORE >>
  • 04/15/2012
    XTL BIOPHARMACEUTICALS LTD. CONVENES AN EXTRAORDINARY GENERAL MEETING
    READ MORE >>
  • 04/15/2012
    XTL BIOPHARMACEUTICALS LTD. NAMES DR. BEN-ZION WEINER TO ITS BOARD OF DIRECTORS
    READ MORE >>
  • 03/29/2012
    XTL BIOPHARMACEUTICALS PRESENTS ITS FINANCIAL STATEMENTS FOR THE YEAR ENDED ON DECEMBER 31, 2011
    READ MORE >>
  • 03/19/2012
    XTL BIOPHARMACEUTICALS ANNOUNCES RESULTS OF ITS ANNUAL GENERAL MEETING OF SHAREHOLDERS
    READ MORE >>
  • 03/18/2012
    XTL BIOPHARMACEUTICALS SUCCESSFULLY COMPLETES A CAPITAL RAISE OF APPROXIMATELY NIS 9.1 MILLION LED BY INSTITUTIONAL INVESTORS
    READ MORE >>
  • 03/06/2012
    XTL BIOPHARMACEUTICALS LTD. APPLIES TO LIST ITS ADRS ON NASDAQ
    READ MORE >>
  • 02/13/2012
    XTL BIOPHARMACEUTICALS CONVENES AN ANNUAL GENERAL MEETING
    READ MORE >>